These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 10448412)
1. Influenza myositis and rhabdomyolysis in an HIV positive man: was zidovudine a co-factor? Guha I; Brook MG Sex Transm Infect; 1999 Jun; 75(3):204-5. PubMed ID: 10448412 [No Abstract] [Full Text] [Related]
3. Blunted humoral response to influenza vaccination in patients exposed to zidovudine plus trimethoprim-sulfamethoxazole. Feola DJ; Garvy BA; Rapp RP; Thornton AC Pharmacotherapy; 2007 Jul; 27(7):937-47. PubMed ID: 17594199 [TBL] [Abstract][Full Text] [Related]
4. [Rapid development of anemia in a HIV-positive patient with alpha-thalassemia after zidovudine therapy]. Altinbaş A; Ozkaya G; Büyükaşik Y; Unal S Mikrobiyol Bul; 2007 Jul; 41(3):473-6. PubMed ID: 17933262 [TBL] [Abstract][Full Text] [Related]
5. Dilated cardiomyopathy in an adult human immunodeficiency virus type 1-positive patient treated with a zidovudine-containing antiretroviral regimen. Tanuma J; Ishizaki A; Gatanaga H; Kikuchi Y; Kimura S; Hiroe M; Oka S Clin Infect Dis; 2003 Oct; 37(7):e109-11. PubMed ID: 13130421 [TBL] [Abstract][Full Text] [Related]
6. Physical signs for the general dental practitioner. Case 49. Zidovudine (AZT or Retrovir) treatment. Bain S Dent Update; 2007 Nov; 34(9):596. PubMed ID: 18087932 [No Abstract] [Full Text] [Related]
7. Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection. Yamamoto Y; Yasuoka A; Yasuoka C; Genka I; Teruya K; Kikuchi Y; Tachikawa N; Oka S Jpn J Infect Dis; 2000 Dec; 53(6):244-5. PubMed ID: 11227023 [No Abstract] [Full Text] [Related]
8. The role of zidovudine in development of lipoatrophy. Moyle GJ AIDS Read; 2005 Nov; 15(11):591-4, 599-600, 603. PubMed ID: 16329181 [No Abstract] [Full Text] [Related]
9. No adverse effects in infants following short-course zidovudine. AIDS Read; 2001 Feb; 11(2):81. PubMed ID: 11279877 [No Abstract] [Full Text] [Related]
10. Tolerability of postexposure prophylaxis with zidovudine, lamivudine, and nelfinavir for human immunodeficiency virus infection. Rabaud C; Bevilacqua S; Beguinot I; Dorvaux V; Schuhmacher H; May T; Canton P Clin Infect Dis; 2001 May; 32(10):1494-5. PubMed ID: 11317252 [TBL] [Abstract][Full Text] [Related]
11. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen. Cameron DW; Becker S; King MS; da Silva B; Klein C; Tokimoto D; Foit C; Calhoun D; Bernstein B; Hanna GJ J Antimicrob Chemother; 2007 May; 59(5):957-63. PubMed ID: 17350990 [TBL] [Abstract][Full Text] [Related]
12. Preventable zidovudine overdose during postnatal prophylaxis in healthy children born to HIV-1-positive mothers. Chiappini E; Galli L; Gabiano C; Gattinara GC; Martino A; Scolfaro C; de Martino M AIDS; 2008 Jan; 22(2):316-7. PubMed ID: 18097238 [No Abstract] [Full Text] [Related]
14. [Myositis and rhabdomyolysis with influenza infection]. Ozawa H; Noma S; Nonaka I Nihon Rinsho; 2000 Nov; 58(11):2276-81. PubMed ID: 11225317 [TBL] [Abstract][Full Text] [Related]
15. Altered bleeding time associated with ibuprofen and zidovudine use. Pieper B; Smitherman HC Nurse Pract; 1998 May; 23(5):74-5, 80, 83. PubMed ID: 9614682 [TBL] [Abstract][Full Text] [Related]
16. [Mitochondrial toxicity: a case of palpebral ptosis in a woman infected by HIV and treated with HAART including zidovudine]. Zannou DM; Azon-Kouanou A; Bashi BJ; Gougounon A; Zinsou R; Adé G; Houngbè F Bull Soc Pathol Exot; 2009 May; 102(2):97-8. PubMed ID: 19583030 [TBL] [Abstract][Full Text] [Related]
18. Painless periungual pyogenic granulomata associated with reverse transcriptase inhibitor therapy in a patient with human immunodeficiency virus infection. Williams LH; Fleckman P Br J Dermatol; 2007 Jan; 156(1):163-4. PubMed ID: 17199585 [No Abstract] [Full Text] [Related]
19. Tolerability of postexposure prophylaxis with the combination of zidovudine-lamivudine and lopinavir-ritonavir for HIV infection. Rabaud C; Burty C; Grandidier M; Christian B; Penalba C; Béguinot I; Jeanmaire H; May T Clin Infect Dis; 2005 Jan; 40(2):303-5. PubMed ID: 15655751 [TBL] [Abstract][Full Text] [Related]
20. Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children. Viganò A; Giacomet V Antivir Ther; 2005; 10 Suppl 2():M53-64. PubMed ID: 16152706 [No Abstract] [Full Text] [Related] [Next] [New Search]